Phase
Condition
Cardiac Disease
Chest Pain
Cardiovascular Disease
Treatment
Ultimaster™ Tansei™ stents
Clinical Study ID
Ages > 19 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patients ≥ 19 years old
Patients receiving Ultimaster™ Tansei™ stents.
The patient or guardian agrees to the study protocol and the schedule of clinicalfollow-up and provides informed, written consent, as approved by the appropriateInstitutional Review Board/Ethics Committee of the respective clinical site.
Exclusion
Exclusion Criteria:
Patients with a mixture of other drug-eluting stents (DESs)
Terminal illness with life-expectancy ≤1 year.
Patients with cardiogenic shock
Study Design
Connect with a study center
Gangwon National Univ. Hospital
Chuncheon,
Korea, Republic ofActive - Recruiting
Daegu Catholic University Medical Center
Daegu,
Korea, Republic ofActive - Recruiting
Keimyung University Dongsan Medical Center
Daegu,
Korea, Republic ofActive - Recruiting
The Catholic University of Korea, Daejeon ST. Mary's Hospital
Daejeon,
Korea, Republic ofActive - Recruiting
Gangneung Asan Hospital
Gangneung,
Korea, Republic ofActive - Recruiting
Kwangju Christian Hospital
Kwangju,
Korea, Republic ofActive - Recruiting
Pusan National University Hospital
Pusan,
Korea, Republic ofActive - Recruiting
Asan Medical Center
Seoul,
Korea, Republic ofActive - Recruiting
Kangdong Sacred Heart Hospital
Seoul,
Korea, Republic ofActive - Recruiting
The Catholic Univ. of Korea Eunpyeong St. Mary's hospital
Seoul,
Korea, Republic ofSite Not Available
St.Carollo Hospital
Suncheon,
Korea, Republic ofActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.